XTL Biopharmaceuticals Ltd.

NasdaqCM:XTLB Stock Report

Market Cap: US$31.0m

XTL Biopharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Shlomo Shalev

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.3yrs
CEO ownership0.2%
Management average tenureno data
Board average tenure9.5yrs

Recent management updates

Recent updates


CEO

Shlomo Shalev (62 yo)

4.3yrs

Tenure

Mr. Shlomo Spokone Shalev serves as Chief Executive Officer at XTL Biopharmaceuticals Ltd. since May 19, 2020. He has been the Chairman of the board of directors at G.F.C Green Fields Capital Ltd.since 1...


Board Members

NamePositionTenureCompensationOwnership
Shlomo Shalev
CEO & Director9.8yrsno data0.25%
$ 76.4k
Doron Turgeman
Non-Executive Chairman of the Board9.8yrsno data0.028%
$ 8.6k
Lee Simon
Member of Clinical Advisory Boardno datano datano data
Daniel Wallace
Member of Clinical Advisory Boardno datano datano data
Jonathan Schapiro
Non-Executive Director9.8yrsno data0%
$ 0
Dobroslav Melamed
Independent Non-Executive Director9.8yrsno data0%
$ 0
Murray Urowitz
Member of Clinical Advisory Boardno datano datano data
Osnat Fain
Independent Non-Executive & External Director9.5yrsno data0%
$ 0
David Isenberg
Member of Clinical Advisory Board9yrsno datano data
Robert Fox
Member of Clinical Advisory Board7.6yrsno datano data
Simon Bowman
Member of Clinical Advisory Board7.6yrsno datano data
Alexander Rabinovich
Non-Executive Director7.4yrsno datano data

9.5yrs

Average Tenure

58yo

Average Age

Experienced Board: XTLB's board of directors are considered experienced (9.5 years average tenure).